News
MOTS-c Cardiac Research: Rat-Heart Findings
A 2026 isolated-rat-heart study links MOTS-c with mitochondrial stress responses, while leaving human relevance and mechanisms open.
GHK-Cu Hair Research: What 14 Trials Show
A 2026 systematic review assessed 14 clinical trials of peptide-containing hair formulations and explains why formulation and evidence grading matter.
NNC0130 Phase 1: Oral and Subcutaneous Findings
What a Phase 1 study reports about NNC0130, a dual GLP-1R/GIPR agonist tested by oral and subcutaneous routes.
MOTS-c fibrosis study: a promising computational lead
A 2026 study links MOTS-c to a computational fibrosis hypothesis in radiation proctitis, while stressing that laboratory validation is still required.
Retatrutide and Kidney Research: What a 2026 Review Reports
Retatrutide kidney research in a 2026 review: what is known about renal markers, mechanisms and the limits of current evidence.
MOTS-c and Exercise Capacity: Key 2026 Findings
A cross-sectional study linked serum MOTS-c with exercise capacity and blood markers in young men, while leaving causality unresolved.
MOTS-c and Diabetic Kidney Injury: What a 2026 Study Reports
A preclinical study links MOTS-c with lipid clearance and reduced kidney injury in diabetic mouse and cell models, with important limits.
Retatrutide and Sleep Apnoea: What 2 Trials Report
Two phase 3 trials report how retatrutide changed the apnoea-hypopnoea index in adults with obstructive sleep apnoea.
Human evidence for BPC-157: what the systematic review found
Human evidence for BPC-157: a 2026 systematic review found only three human studies involving 30 participants, with very low certainty and serious methodological limitations.
MOTS-c and Ageing Ovarian Cells: What the Study Reports
A laboratory and mouse study links MOTS-c with bioenergetic changes in ageing-associated ovarian models, without testing human fertility outcomes.